Showing results (121-130 of 175) with videos related to

Sort By:
Pageof 18
Histopathology|August 27, 2021
Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 casesBin Xu, Julia David, Snjezana Dogan, et al.
International Journal of Cancer|January 30, 2019
MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancerOfra Novoplansky, Matthew Fury, Manu Prasad, et al.
The Journal of Experimental Medicine|April 24, 2025
Sympathetic axonogenesis promotes adenoid cystic carcinoma progressionChun-Hao Chen, Boris Reva, Nora Katabi, et al.
The American Journal of Surgical Pathology|August 11, 2016
Undifferentiated Carcinoma With Osteoclastic Giant Cells of the Pancreas: Clinicopathologic Analysis of 38 Cases Highlights a More Protracted Clinical Course Than Currently AppreciatedTakashi Muraki, Michelle D Reid, Olca Basturk, et al.
Genes, Chromosomes & Cancer|April 13, 2011
EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary glandCristina R Antonescu, Nora Katabi, Lei Zhang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 25, 2012
Secondary mutation in a coding mononucleotide tract in MSH6 causes loss of immunoexpression of MSH6 in colorectal carcinomas with MLH1/PMS2 deficiencyJinru Shia, Liying Zhang, Moshe Shike, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2024
Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic CarcinomaAntoine Desilets, Joris L Vos, Nora Katabi, et al.
Head & Neck|April 2, 2019
Organ preservation for patients with anterior mucosal squamous cell carcinoma of the nasal cavity: Rhinectomy-free survival in those refusing surgeryXimena Mimica, Yao Yu, Marlena McGill, et al.
Oncotarget|January 6, 2017
Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATMJennifer Ma, Jeremy Setton, Luc Morris, et al.
The Journal of Pathology|September 30, 2024
Expanding the clinicopathologic spectrum and genomic landscape of tumors with SMARCA2/4::CREM fusionsJoanna Cyrta, Josephine K Dermawan, Arnault Tauziède-Espariat, et al.
Pageof 18